首页 | 本学科首页   官方微博 | 高级检索  
     


Neoadjuvant Chemotherapy Using Reduced‐Dose Docetaxel Followed by Radical Prostatectomy for Patients With Intermediate and High‐Risk Prostate Cancer: A Single‐Center Study
Authors:Alexander Nosov  Sergey Reva  Sergey Petrov  Eldar Mamijev  Roman Novikov  Evgeniy Veliev  Florian Imkamp  Yuri Tolkach  Vladimir Moiseenko
Affiliation:1. Department of Oncological Urology, Petrov N.N. Research Institute of Oncology, Saint‐Petersburg, Russia;2. Urology Clinic of the S.P. Botkin City Clinical Hospital, Moscow, Russia;3. Clinic for Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany;4. Institute of Pathology, University Hospital of Bonn, Bonn, Germany;5. Saint‐Petersburg Oncological Center, Saint‐Petersburg, Russia
Abstract:
Keywords:prostate cancer  radical prostatectomy  neoadjuvant chemotherapy  docetaxel  survival
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号